BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raggi A, Plazzi G, Ferri R. Health-Related Quality of Life in Patients With Narcolepsy: A Review of the Literature. J Nerv Ment Dis 2019;207:84-99. [DOI: 10.1097/nmd.0000000000000918] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Qu S, Wang P, Wang M, Li C, Dong X, Xu L, Han F. A comparison of mood, quality of life and executive function among narcolepsy type 1 patients with or without ADHD symptoms in China. Sleep Medicine 2022. [DOI: 10.1016/j.sleep.2022.05.016] [Reference Citation Analysis]
2 Li C, Xie L, Shang S, Dong X, Wang X, Zhao L, Zhang C, Han F. Narcolepsy Quality-of-Life Instrument with 21 Questions: A Translation and Validation Study in Chinese Pediatric Narcoleptics. Nat Sci Sleep 2021;13:1701-10. [PMID: 34675719 DOI: 10.2147/NSS.S322796] [Reference Citation Analysis]
3 Shaffer SM, Emerson AJ, Burr M, Einhorn L, Naze GS. Quality of life in painful temporomandibular disorders onset: a systematic review of outcome measure clinimetrics and predictive properties. Physical Therapy Reviews 2021;26:284-98. [DOI: 10.1080/10833196.2021.1914955] [Reference Citation Analysis]
4 Abad VC. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives. Nat Sci Sleep 2021;13:75-91. [PMID: 33531850 DOI: 10.2147/NSS.S245020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
5 Iranzo A, Serralheiro P, Schuller JC, Schlit AF, Bentz JWG. Evaluation of the Effectiveness of the Risk Minimization Measures of Sodium Oxybate in the European Union. Drugs Real World Outcomes 2020;7:307-15. [PMID: 32989679 DOI: 10.1007/s40801-020-00212-9] [Reference Citation Analysis]
6 Barker EC, Flygare J, Paruthi S, Sharkey KM. Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns. Nat Sci Sleep 2020;12:453-66. [PMID: 32765142 DOI: 10.2147/NSS.S162762] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
7 Franceschini C, Fante C, Filardi M, Folli MC, Brazzi F, Pizza F, D'Anselmo A, Ingravallo F, Antelmi E, Plazzi G. Can a Peer Support the Process of Self-Management in Narcolepsy? A Qualitative Narrative Analysis of a Narcoleptic Patient. Front Psychol 2020;11:1353. [PMID: 32733314 DOI: 10.3389/fpsyg.2020.01353] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Ingravallo F, Vignatelli L, Pagotto U, Vandi S, Moresco M, Mangiaruga A, Oriolo C, Zenesini C, Pizza F, Plazzi G. Protocols of a diagnostic study and a randomized controlled non-inferiority trial comparing televisits vs standard in-person outpatient visits for narcolepsy diagnosis and care: TElemedicine for NARcolepsy (TENAR). BMC Neurol 2020;20:176. [PMID: 32393279 DOI: 10.1186/s12883-020-01762-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bolin K, Niska PÅ, Pirhonen L, Wasling P, Landtblom AM. The cost utility of pitolisant as narcolepsy treatment. Acta Neurol Scand 2020;141:301-10. [PMID: 31838740 DOI: 10.1111/ane.13202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Quaedackers L, De Wit J, Pillen S, Van Gilst M, Batalas N, Lammers GJ, Markopoulos P, Overeem S. A Mobile App for Longterm Monitoring of Narcolepsy Symptoms: Design, Development, and Evaluation. JMIR Mhealth Uhealth 2020;8:e14939. [PMID: 31909723 DOI: 10.2196/14939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Aguilar AC, Frange C, Pimentel Filho LH, Reis MJ, Tufik S, Coelho FMS. Lisdexamfetamine to improve excessive daytime sleepiness and weight management in narcolepsy: a case series. Braz J Psychiatry 2020;42:314-6. [PMID: 31859793 DOI: 10.1590/1516-4446-2019-0544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Pascoe M, Bena J, Foldvary-Schaefer N. Effects of Pharmacotherapy Treatment on Patient-Reported Outcomes in a Narcolepsy and Idiopathic Hypersomnia Cohort. J Clin Sleep Med 2019;15:1799-806. [PMID: 31855165 DOI: 10.5664/jcsm.8088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]